Spinal Cord Stimulation In Management Research Articles

ID: 332687 Spinal cord stimulation for management of CRPS type 2 in setting of arterial insufficiency

ID: 332687 Spinal cord stimulation for management of CRPS type 2 in setting of arterial insufficiency

Systematic review of efficacy of Spinal Cord Stimulation for management of pain in Chronic Pancreatitis

Systematic review of efficacy of Spinal Cord Stimulation for management of pain in Chronic Pancreatitis

Cervical Spinal Cord Stimulation for Facial Pain.

Neuropathic facial pain can be exceedingly difficult to manage with conventional therapies. Since this pain may be excruciating and often debilitating and some patients do not respond or do not tolerate conventional treatments, the interest in neuromodulation therapies is increasing. One of the most commonly used neuromodulation therapies, spinal cord stimulation, has recently shown promise in treating facial pain. We reviewed the current literature to determine usefulness of spinal cord stimulation in management of refractory facial pain. Our review indicates that for some patients with intractable pain in portions of the face, cervical spinal cord stimulation may be effective at reducing pain.

Spinal Cord Stimulation in Management of Intractable Chronic Pain: A 5-Year Experience

Background: We investigated the effect of spinal cord stimulation on intractable chronic pain retrospectively and report our 5-year experience.Methods: 49 patients with the medical history of trial spinal cord stimulation have been retrospectively analyzed. They consist of 34 men and 15 women, ranging in age from 22 to 89 years. Causes of intractable chronic pain included postherpetic neuralgia, failed back surgery syndrome, complex regional pain syndrome, chronic back and leg pain, cauda equina syndrome, perineal pain, diabetic polyneuropathy, and spinal cord injury.Results: The pain due to failed back surgery syndrome, complex regional pain syndrome, chronic low back and leg pain, and spinal cord injury was well controlled by using spinal cord stimulation system. After a trial period of stimulation, 20 patients had permanent stimulators implanted. Most of them reported satisfactory pain relief for maximum 60 months and minimum 9 months. Noticeable complications included electrode displacement and hemorrhage. Conclusions: We may suggest that spinal cord stimulation is an effective and safe therapy for chronic intractable pain.

Spinal-cord stimulation in management of angina

Spinal-cord stimulation in management of angina

Spinal cord stimulation in management of chronic pain

Between 1978 and 1986, 109 patients with chronic pain underwent spinal cord stimulation (SCS) at the authors' institute as part of their pain treatment program. The results of SCS in these patients at the end of the test period and at the latest follow-up examination are analyzed in relation to the etiology of their pain. In 40 patients pain was associated with an obstructive peripheral vasculopathy, in 10 with a previous herpes zoster infection, in 15 with an incomplete traumatic spinal cord lesion, in nine with root and/or nerve damage, in 11 with cancer, and in 19 with previous back surgery. The etiology of the pain in five patients was uncertain. This experience supports the conclusion that the best indications for SCS are vasculopathic pain and post-herpetic neuralgia. No clinical usefulness was found for SCS in cancer pain or in central deafferentation types of pain.